BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 12051932)

  • 1. Contrasting IgG structures reveal extreme asymmetry and flexibility.
    Saphire EO; Stanfield RL; Crispin MD; Parren PW; Rudd PM; Dwek RA; Burton DR; Wilson IA
    J Mol Biol; 2002 May; 319(1):9-18. PubMed ID: 12051932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Fab and Fc fragments of IgA1 exhibit a different arrangement from that in IgG: a study by X-ray and neutron solution scattering and homology modelling.
    Boehm MK; Woof JM; Kerr MA; Perkins SJ
    J Mol Biol; 1999 Mar; 286(5):1421-47. PubMed ID: 10064707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Refined structure of an intact IgG2a monoclonal antibody.
    Harris LJ; Larson SB; Hasel KW; McPherson A
    Biochemistry; 1997 Feb; 36(7):1581-97. PubMed ID: 9048542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The three-dimensional structure of an intact monoclonal antibody for canine lymphoma.
    Harris LJ; Larson SB; Hasel KW; Day J; Greenwood A; McPherson A
    Nature; 1992 Nov; 360(6402):369-72. PubMed ID: 1448155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of the murine unglycosylated IgG1 Fc fragment.
    Feige MJ; Nath S; Catharino SR; Weinfurtner D; Steinbacher S; Buchner J
    J Mol Biol; 2009 Aug; 391(3):599-608. PubMed ID: 19559712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgG2 Fc structure and the dynamic features of the IgG CH2-CH3 interface.
    Teplyakov A; Zhao Y; Malia TJ; Obmolova G; Gilliland GL
    Mol Immunol; 2013 Nov; 56(1-2):131-9. PubMed ID: 23628091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disulfide connectivity of human immunoglobulin G2 structural isoforms.
    Martinez T; Guo A; Allen MJ; Han M; Pace D; Jones J; Gillespie R; Ketchem RR; Zhang Y; Balland A
    Biochemistry; 2008 Jul; 47(28):7496-508. PubMed ID: 18549248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystallographic structure of an intact IgG1 monoclonal antibody.
    Harris LJ; Skaletsky E; McPherson A
    J Mol Biol; 1998 Feb; 275(5):861-72. PubMed ID: 9480774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of biological activity among nonfucosylated therapeutic IgG1 antibodies with three different N-linked Fc oligosaccharides: the high-mannose, hybrid, and complex types.
    Kanda Y; Yamada T; Mori K; Okazaki A; Inoue M; Kitajima-Miyama K; Kuni-Kamochi R; Nakano R; Yano K; Kakita S; Shitara K; Satoh M
    Glycobiology; 2007 Jan; 17(1):104-18. PubMed ID: 17012310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis for a disfavored elimination reaction in catalytic antibody 1D4.
    Larsen NA; Heine A; Crane L; Cravatt BF; Lerner RA; Wilson IA
    J Mol Biol; 2001 Nov; 314(1):93-102. PubMed ID: 11724535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flexibility of human IgG subclasses.
    Roux KH; Strelets L; Michaelsen TE
    J Immunol; 1997 Oct; 159(7):3372-82. PubMed ID: 9317136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Site-specific N-glycosylation of chicken serum IgG.
    Suzuki N; Lee YC
    Glycobiology; 2004 Mar; 14(3):275-92. PubMed ID: 14693911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The crystal structure of the pathogenic collagen type II-specific mouse monoclonal antibody CIIC1 Fab: structure to function analysis.
    Uysal H; Sehnert B; Nandakumar KS; Böiers U; Burkhardt H; Holmdahl R; Thunnissen MM
    Mol Immunol; 2008 Apr; 45(8):2196-204. PubMed ID: 18241923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conjugation of human Fc gamma in closed-hinge or open-hinge configuration to Fab'gamma and analogous ligands.
    Stevenson GT; Anderson VA; Kan KS; Worth AT
    J Immunol; 1997 Mar; 158(5):2242-50. PubMed ID: 9036971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global structure of HIV-1 neutralizing antibody IgG1 b12 is asymmetric.
    Ashish ; Solanki AK; Boone CD; Krueger JK
    Biochem Biophys Res Commun; 2010 Jan; 391(1):947-51. PubMed ID: 19995532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure and stability changes of human IgG1 Fc as a consequence of methionine oxidation.
    Liu D; Ren D; Huang H; Dankberg J; Rosenfeld R; Cocco MJ; Li L; Brems DN; Remmele RL
    Biochemistry; 2008 May; 47(18):5088-100. PubMed ID: 18407665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural characterization of a mutated, ADCC-enhanced human Fc fragment.
    Oganesyan V; Damschroder MM; Leach W; Wu H; Dall'Acqua WF
    Mol Immunol; 2008 Apr; 45(7):1872-82. PubMed ID: 18078997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 3.2-A crystal structure of the human IgG1 Fc fragment-Fc gammaRIII complex.
    Sondermann P; Huber R; Oosthuizen V; Jacob U
    Nature; 2000 Jul; 406(6793):267-73. PubMed ID: 10917521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solution structure determination of monomeric human IgA2 by X-ray and neutron scattering, analytical ultracentrifugation and constrained modelling: a comparison with monomeric human IgA1.
    Furtado PB; Whitty PW; Robertson A; Eaton JT; Almogren A; Kerr MA; Woof JM; Perkins SJ
    J Mol Biol; 2004 May; 338(5):921-41. PubMed ID: 15111057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrasting glycosylation profiles between Fab and Fc of a human IgG protein studied by electrospray ionization mass spectrometry.
    Mimura Y; Ashton PR; Takahashi N; Harvey DJ; Jefferis R
    J Immunol Methods; 2007 Sep; 326(1-2):116-26. PubMed ID: 17714731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.